High versus standard adalimumab induction dosing regimens in patients with moderately to severely active ulcerative colitis: results from the SERENE-UC induction study

Julian Panés  ¹     Jean-Frederic Colombel  ²     Geert R. D'Haens  ³     Stefan Schreiber  ⁴     Remo Panaccione  ⁵     Laurent Peyrin-Biroulet  ⁶     Edward Loftus, Jr     Silvio Danese     Edouard Louis     Alessandro Armuzzi     Marc Ferrante     Harald Vogelsang     Jessica Lefebvre     Thao Doan     Nisha V. Kwatra     Nael M. Mostafa     Wangang Xie     Bidan Huang     Joel Petersson;;    
¹ Hospital Clinic de Barcelona,Barcelona,Spain
² Icahn School of Medicine at Mount Sinai,New York,United States
³ AMC Amsterdam Inflammatory Bowel Disease Centre - Academic Medical Center, AMC Amsterdam Inflammator,Amsterdam,Netherlands
⁴ University Hospital Schleswig-Holstein,Kiel,Germany
⁵ University of Calgary,Calgary,Canada
⁶ Nancy Unive

Session
Paradigm shifts in IBD treatment

Conference
UEG Week 2019

Citation
United European Gastroenterology Journal Volume 7 Issue 8 (Supplement), October 2019